glp 1 disorders Eating The multifaceted role of GLP-1

However, clinical data confirms that weight loss is significantly slower with microdosing compared to standard therapeutic doses, often resulting in much less total weight loss over the same period

Gastrointestinal Adverse Effects of GLP-1 and Dual GLP-1/GIP Receptor Agonists: A Comprehensive Update in Diabetic and Obese Populations

Journal of Molecular Endocrinology , 64

To reduce side effects, clinicians typically begin at the lowest dose and increase slowly

Mechanisms and possible hepatoprotective effects of glucagon-like peptide-1 receptor agonists and other incretin receptor agonists in non-alcoholic fatty liver disease